Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Substance-Related Disorders Clinical Trial

Official title:

Effectiveness of Self-Help for Dually-Diagnosed Persons

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00218582
• Other study ID #: NIDA-15912-1
• Secondary ID: R01-15912-1
• Status: Completed
• Phase: Phase 1/Phase 2
• First received: September 20, 2005
• Last updated: January 11, 2017
• Start date: March 2003
• Est. completion date: March 2007

Study information

• Verified date: October 2008
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 229
• Est. completion date: March 2007
• Est. primary completion date: March 2007
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

Admission to psychiatric day treatment program 18-64 years old

Exclusion Criteria:

Did not understand or speak English, appeared intoxicated on drugs or alcohol, carried a diagnosis of mental retardation, were deemed actively psychotic by the clinic's intake coordinator, appeared unable to understand and give informed consent.

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Disease
• Dual Diagnosis
• Mental Disorders
• Psychotic Disorders
• Substance-Related Disorders

Intervention

Behavioral:
• Double Trouble in Recovery
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
• Standard psychiatric day treatment
Individual counseling, groups, medication

Locations

Country	Name	City	State
United States	Albert Einstein Dept of Psychiatry	Bronx	New York

Sponsors (2)

Lead Sponsor	Collaborator
National Institute on Drug Abuse (NIDA)	National Development and Research Institutes, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (1)

Magura S, Rosenblum A, Villano CL, Vogel HS, Fong C, Betzler T. Dual-focus mutual aid for co-occurring disorders: a quasi-experimental outcome evaluation study. Am J Drug Alcohol Abuse. 2008;34(1):61-74. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	drug/alcohol use		past 90 days	No
Secondary	psychiatric medication adherence		recent	No
Secondary	traditional 12 step meeting attendance		past 90 days	No
Secondary	psychiatric symptoms		recent	No
Secondary	program retention		up to 6 months	No